Did AFP‐L3 save ultrasonography in community screening?

The Kaohsiung Journal of Medical Sciences - Tập 34 - Trang 583-587 - 2018
Chih-Wei Yen1, Yuan-Hung Kuo2, Jing-Houng Wang2, Kuo-Chin Chang2, Kwong-Ming Kee2, Shu-Feng Hung2, Yi Chen3, Lin-San Tsai3, Shu-Chuan Chen3, Chao-Hung Hung1, Sheng-Nan Lu1
1Division of Hepatogastroenterology, Department of Internal Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan
2Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan
3Department of Health, Tainan City Government, Tainan, Taiwan

Tóm tắt

AbstractIn the community screening, those subjects with elevated serum alpha‐fetoprotein (AFP) required further abdomen ultrasonography (US) to detect hepatocellular carcinoma (HCC). However, some chronic hepatitis patients might have elevated AFP. AFP‐L3, has been proposed to differentiate HCC and hepatitis in elevated AFP cases in Japan for decades, but the utility is limited outside Japan. We conducted this study to elucidate the role of AFP‐L3 in the community and the possibility of saving unnecessary US. A total of 56,702 subjects underwent a large‐scale healthcare screening in Tainan county in 2004. Among them, 286 residents with AFP more than 20 ng/ml further received US and 169 (59%) had stored baseline sera were enrolled into this study in 2013. Their AFP and AFP‐L3 levels were further detected. HCC patients were initially identified through US and personal history. Among 169 studied sera, only 148 (87.6%) samples still had AFP level more than 20 ng/ml after a 10‐years frozen period. The decrease of AFP level was significant (481.3 ± 2093.8 ng/ml and 456.1 ± 2095.3 ng/ml in paired‐T test, p < 0.001). Focusing on these 148 cases, 23 (15.5%) HCC cases were diagnosed at the baseline screening. There was no difference of AFP‐L3 level between HCC and non‐HCC cases. Using AFP‐L3 to predict HCC, the area under Receiver Operating Characteristic curve was as low as 52%, p = 0.757. Too long frozen period might lower the quality of stored sera. Additionally, AFP‐L3 might not provide more information for HCC identification to save advanced US examinations in the community screening.

Tài liệu tham khảo

2013, Department of Health: Health statistics, 2012. Taipei 10.1200/JCO.2011.36.2335 10.1111/j.1440-1746.2006.04425.x 10.1016/j.ejca.2009.12.018 10.1038/ajg.2012.445 10.1159/000333257 10.1055/s-2005-915649 10.3747/co.v18i5.952 10.1111/j.1600-0676.1986.tb00279.x Giulia M., 2010, Serum markers of hepatocellular carcinoma, Dig Dis Sci, 55, 2744, 10.1007/s10620-010-1184-7 Imamura M., 1999, Usefulness of Lens culinaris agglutinin A‐reactive fraction of alpha‐fetoprotein (AFP‐L3) as a marker of distant metastasis from hepatocellular carcinoma, Oncol Rep, 6, 1229 10.1016/S0168-8278(99)80016-6 10.1159/000327577 10.1111/j.1440-1746.2010.06476.x 10.1111/j.1440-1746.2006.04489.x 10.1158/1055-9965.EPI-07-2746 10.1038/ajg.2009.711 10.1111/j.1440-1746.2010.06300.x 10.1111/j.1440-1746.2010.06285.x 10.1111/j.1440-1746.2012.07212.x 10.1515/CCLM.2007.262 10.1097/00004836-200103000-00014 Taketa K., 2002, Evaluation of tumor markers for the detection of hepatocellular carcinoma in Yangon General Hospital, Myanmar, Acta Med Okayama, 56, 317 10.1177/172460080101600204 Houwert A.C., 2012, Alphafetoprotein in the Dutch external quality assurance programme: a need for improvement, Ann Clin Biochem, 49, 273, 10.1258/acb.2011.011046 10.1159/000367735